MOBOCERTINIB - AN OVERVIEW

Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; generally known as FRAP-relevant protein (FRP1)) has emerged like a promising system for cancer procedure that exploits synthetic lethal interactions with proteins involved with DNA injury repair, overcomes resistance to other therapies an